A
Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
NSE:ABBOTINDIA
Price:
25 820.0508 INR
-1.19%
Market Closed
Updated:
May 6, 2024
Abbott India Ltd
Cash from Investing Activities
|
Abbott India Ltd
Cash from Investing Activities Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Cash from Investing Activities
-₹1.5B
|
CAGR 3-Years
28%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Investing Activities
-₹54.9B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Investing Activities
-₹25.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Investing Activities
-₹55.9B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Investing Activities
₹10B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Investing Activities
-₹20.1B
|
CAGR 3-Years
-63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott India Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.5B
INR
-1.5B
INR
Based on the financial report for Mar 31, 2023, Abbott India Ltd's Cash from Investing Activities amounts to -1.5B INR.
What is Abbott India Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
7%
7%
Over the last year, the Cash from Investing Activities growth was 63%. The average annual Cash from Investing Activities growth rates for Abbott India Ltd have been 28% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
